Bcel stock forecast.

5 equities research analysts have issued twelve-month target prices for Atreca's stock. Their BCEL share price targets range from $4.00 to $25.00. On average, they expect the company's stock price to reach $10.75 in the next twelve months. This suggests a possible upside of 4,474.5% from the stock's current price.The current average BCEL price target, as estimated by these analysts, is $4.00. The predictions for the future BCEL stock price range from a low of $4.00 to a high of $4.00, highlighting the variability of market expectations for BCEL. BCEL Earnings Date and Information. Atreca last posted its quarterly earnings data on May 10th, 2023. The reported ($0.54) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.56) by $0.02. Atreca has generated ($2.18) earnings per share over the last year ( ($2.18) diluted earnings per share).Average. $3.25. Current Price. $0.21. Options. Overview. Research & Ratings. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume ...Detailed statistics for Atreca, Inc. (BCEL) stock, including valuation metrics, financial numbers, share information and more. Detailed statistics for Atreca, Inc. (BCEL) stock, including valuation metrics, financial numbers, share information and more. ... Analyst Forecast. The average price target for Atreca is $3.38, which is 1,415.70% ...

Based on 10 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. The average price target is $24.40 with a high forecast of $33.00 and a low forecast of $20.00. The average price target represents a 29.93% change from the last price of $18.78. Highest Price Target $33.00. Average Price Target $24.40.

About the Atreca Inc – Class A stock forecast. As of 2023 November 08, Wednesday current price of BCEL stock is 0.290$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).

The 360 Finance, Inc. stock price fell by -2.78% on the last day (Wednesday, 22nd Nov 2023) from $16.53 to $16.07. During the last trading day the stock fluctuated 4.68% from a day low at $15.81 to a day high of $16.55. The price has risen in 6 of the last 10 days and is up by 4.15% over the past 2 weeks.5 equities research analysts have issued twelve-month target prices for Atreca's stock. Their BCEL share price targets range from $4.00 to $25.00. On average, they expect the company's stock price to reach $10.75 in the next twelve months. This suggests a possible upside of 4,474.5% from the stock's current price.For Atreca stock forecast for 2023, 1 predictions are offered for each month of 2023 with average Atreca stock forecast of $0.23, a high forecast of $0.23, and a low forecast of …Atreca Inc (BCEL) Stock Price & News - Google Finance Home BCEL • NASDAQ Atreca Inc Follow Share $0.21 After Hours: $0.22 (2.90%) +0.0062 Closed: Nov 24, 3:00:17 PM GMT-5 · USD · NASDAQ ·... Wall Street Stock Market & Finance report, prediction for the future: You'll find the Hudbay Minerals share forecasts, stock quote and buy / sell signals below. According to present data Hudbay Minerals's HBM shares and potentially its market environment have been in bearish cycle last 12 months (if exists).

Atreca Inc (NASDAQ:BCEL) 0.2302. Delayed Data. As of Nov 30. +0.0047 / +2.19%. Today’s Change. 0.19. Today ||| 52-Week Range. 2.05.

Atreca is forecast to grow earnings and revenue by 10.3% and 9.5% per annum respectively while EPS is expected to grow by 30.2% per annum.

11.30% of Atreca stock is owned by insiders. Which Atreca insiders have been selling company stock? The following insiders have sold BCEL shares in the last 24 months: Bros. Advisors Lp Baker ($109,895.60), John A Orwin ($37,216.24), Phillips Courtney ($15,321.16), and Tito Serafini ($199,122.53).Wall Street Stock Market & Finance report, prediction for the future: You'll find the Viking Therapeutics share forecasts, stock quote and buy / sell signals below. According to present data Viking Therapeutics's VKTX shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).Atreca, Inc. (BCEL.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Atreca, Inc. | Nasdaq: BCEL | Nasdaq2010. 90. John Orwin. https://www.atreca.com. Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified ...BCEL reported Q4'22 and full year earnings on March 29. Cash, cash equivalents and investments were $70.5M at the end of 2022. R&D expenses were $66.8M for 2022 and G&A expenses were $31.5M for ...🚀 Atreca stock price forecast: $4; Market Cap: 11.00M, Enterprise value: 68.43M, P/E: -0.4, PEG ratio: -0.03, EPS: -2.11, Revenue: N/A, EBITDA: -81.73M, Income ...Earnings announcement* for BCEL: Our vendor, Zacks Investment Research, hasn't provided us with the upcoming earnings report date. BCEL has a "high" Earnings Quality Ranking (EQR) for the 5th ...

The average Adma Biologics stock price prediction forecasts a potential upside of 43.11% from the current ADMA share price of $3.96. What is ADMA's forecast return on equity (ROE) for 2023-2026? (NASDAQ: ADMA) forecast ROE is N/A, which is considered weak.In today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.3 Wall Street research analysts have issued 1-year price targets for Tecnoglass' shares. Their TGLS share price targets range from $43.00 to $54.00. On average, they anticipate the company's stock price to reach $48.20 in the next year. This suggests a possible upside of 30.2% from the stock's current price.Find the latest Atreca, Inc. (BCEL) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Weather forecasts play an essential role in our daily lives, helping us plan our activities and stay prepared for any weather conditions that may come our way. One of the most common types of forecasts is the 7-day weather forecast, which p...Atreca Inc [BCEL] stock prices are down -14.82% to $0.28 at the moment. ... An investor can expect a potential return of 1060.71% based on the average BCEL price forecast. Analyzing the BCEL fundamentals. In this publicly-traded organization, revenue per employee is $8,556, ...

BCELNASDAQ 0.2150USD −0.0047 −2.14% At close at Dec 1, 16:12 UTC-8 See on Supercharts Overview News Ideas Financials Technicals Forecast Price target 2.00R …

The consensus price target of analysts on Wall Street is $2.00, which implies an increase of 89.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2.00 and $2.00 respectively. As a result, BCEL is trading at a discount of -809.09% off the target high and -809.09% off the low.For Atreca stock forecast for 2023, 1 predictions are offered for each month of 2023 with average Atreca stock forecast of $0.23, a high forecast of $0.23, and a low forecast of …Find real-time CBAY - CymaBay Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 5.50, with a high estimate of 9.00 and a low estimate of 2.50. The median ...The latest Atreca stock prices, stock quotes, news, and BCEL history to help you invest and trade smarter. ... The 11 analysts offering price forecasts for Atreca have a median target of 11.77 ...Stocks & ETFs, MFs & FOREX. AI Trend Prediction Engine. Stocks & ETFs, MFs & FOREXLNG Stock 12 Months Forecast. Based on 11 Wall Street analysts offering 12 month price targets for Cheniere Energy in the last 3 months. The average price target is $203.36 with a high forecast of $229.00 and a low forecast of $185.00. The average price target represents a 13.00% change from the last price of $179.96.

Find the latest Morphic Holding, Inc. (MORF) stock quote, history, news and other vital information to help you with your stock trading and investing.

Atreca, Inc. (BCEL) stock forecast and price target. Find the latest Atreca, Inc. BCEL analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

QFIN Stock 12 Months Forecast. $25.75. (85.12% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Qifu Technology in the last 3 months. The average price target is $25.75 with a high forecast of $27.00 and a low forecast of $24.50. The average price target represents a 85.12% change from the last price of $13.91.Qifu Technology (NASDAQ:QFIN) pays an annual dividend of $0.98 per share and currently has a dividend yield of 6.10%. QFIN has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 28.16%. This payout ratio is at a healthy, sustainable level, below 75%.VKTX Stock 12 Months Forecast. $34.00. (187.40% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Viking Therapeutics in the last 3 months. The average price target is $34.00 with a high forecast of $40.00 and a low forecast of $28.00. The average price target represents a 187.40% change from the last price of $11.83. Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Nov 6, 2023 · Atreca is forecast to grow earnings and revenue by 10.3% and 9.5% per annum respectively while EPS is expected to grow by 30.2% per annum. The Atreca stock forecast for tomorrow is $ 0.213730, which would represent a -4.16% loss compared to the current price. In the next week, the price of BCEL is expected to decrease by -24.67% and hit $ 0.167988. As far as the long-term Atreca stock forecast is concerned, here’s what our ...Atreca Stock Forecast and Price Target. According to six esteemed experts, the average price target for Atreca to reach this year is $17.00, with a potential upside of approximately 1,600%. This prediction is based on a high estimate of $35.00 and a low estimate of $11.00.Zacks News for BCEL Atreca (BCEL) Suspends Lead Drug Evaluation, Stock Falls 37% 08/14/23-9:51AM EST Zacks Here's Why Atreca, Inc. (BCEL) Is a Great 'Buy the Bottom' Stock Now 04/06/23-8:55AM EST ...The 360 Finance, Inc. stock price fell by -2.78% on the last day (Wednesday, 22nd Nov 2023) from $16.53 to $16.07. During the last trading day the stock fluctuated 4.68% from a day low at $15.81 to a day high of $16.55. The price has risen in 6 of the last 10 days and is up by 4.15% over the past 2 weeks.DUK Stock 12 Months Forecast. $97.00. (4.71% Upside) Based on 11 Wall Street analysts offering 12 month price targets for Duke Energy in the last 3 months. The average price target is $97.00 with a high forecast of $103.00 and a low forecast of $89.00. The average price target represents a 4.71% change from the last price of $92.64.

February 13, 2024. EPS forecast (this quarter) -$0.20. Annual revenue (last year) $185.3M. Annual profit (last year) -$200.2M. Net profit margin.Next reporting date. December 19, 2023. EPS forecast (this quarter) -$0.08. Annual revenue (last year) $130.5M. Annual profit (last year) -$142.7M. Net profit margin. May 6, 2023 · Atreca Stock Forecast and Price Target. According to six esteemed experts, the average price target for Atreca to reach this year is $17.00, with a potential upside of approximately 1,600%. This prediction is based on a high estimate of $35.00 and a low estimate of $11.00. Instagram:https://instagram. cheapest stocks on cashappwhat is stock based compensationabml stock newsstarpax biopharma stock Nov 30, 2023 · Atreca, Inc. (BCEL.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Atreca, Inc. | Nasdaq: BCEL | Nasdaq Zacks Equity Research. April 6, 2023 at 9:55 AM · 3 min read. Shares of Atreca, Inc. (BCEL) have been struggling lately and have lost 20% over the past week. However, a hammer chart pattern was ... superconductor stocksapple iphone delivery Stock Price Forecast The 31 analysts offering 12-month price forecasts for Li Auto Inc have a median target of 51.71, with a high estimate of 79.79 and a low estimate of 35.71. corning stocks According to analyst projections, BCEL’s forecast low is $1.00 with $9.00 as the target high. To hit the forecast high, the stock’s price needs a -4185.71% plunge from its current level, while the stock would need to soar -376.19% for it to hit the projected low. Atreca Inc (BCEL) estimates and forecastsNov 6, 2023 · Atreca is forecast to grow earnings and revenue by 10.3% and 9.5% per annum respectively while EPS is expected to grow by 30.2% per annum. Stock Price Forecast. The 18 analysts offering 12-month price forecasts for Nu Holdings Ltd have a median target of 9.75, with a high estimate of 16.00 and a low estimate of 6.00. The median ...